Faculty Information - Koji Kurose

BooK

Journal

Presentation

Belonging society

（Last updated : 2021-09-16 11:50:30）

Koji Kurose
Department Kawasaki Medical School Kawasaki Medical School, Department of Respiratory Medicine,

Position Assistant Professor

■ BooK

2013/09

Anti-CCR4 mAb and Regulatory T Cells「Japanese Journal of Cancer and Chemotherapy」

■ Journal

1.	2017/12	Nivolumab-induced polyarthritis
2.	2017/03	NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC.
3.	2016/12	Survival of Lung Adenocarcinoma Patients Predicted from Expression of PD-L1, Galectin-9, and XAGE1 (GAGED2a) on Tumor Cells and Tumor-Infiltrating T Cells.
4.	2015/09	Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients.
5.	2015/01	Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an anti-human CCR4 mAb (KM2760).
6.	2015/01	Increase in activated Treg in TIL in lung cancer and in vitro depletion of Treg by ADCC using an anti-human CCR4 mAb (KM2760).
7.	2014/10	Prolongation of overall survival in advanced lung adenocarcinoma patients with the XAGE1 (GAGED2a) antibody.
8.	2014/03	TLR4 and NLRP3 inflammasome activation in monocytes by N-propionyl cysteaminylphenol-maleimide-dextran (NPCMD).
9.	2013/09	Step-down of budesonide/formoterol in early stages of asthma treatment leads to insufficient anti-inflammatory effect.
10.	2011/05	Stability of sealed-bag samples for off-line measurement of fractional exhaled nitric oxide.
11.	2011/04	Outbreak of pertussis in a university laboratory.
Display 5 items
Display all(11)

■ Presentation

1.	2015/09/26	Discriminant function for predicting survival of lung adenocarcinoma patients developed by using immune parameters of PD-L1,Gal-9, and XAGE1 expression on tumor cells and T cell infiltration score. （Poster notice，General）
2.	2015/09/26	Phase Ia study of FoxP3+ CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, （Poster notice，General）
3.	2015/04/17	Clinical effect of XAGE1(GAGED2a) antigen expression and antibody response in EGFR mutated and wild-type advanced lung adenocarcinoma （Speech，General）
4.	2014/10/05	Clinical effect of XAGE1 (GAGED2a) antigen expression and antibody response in EGFR mutated and wild-type advanced lung adenocarcinoma （Poster notice，General）
5.	2014/10/05	Increase of activated Tregs in TIL in lung cancer and in vitro depletion of Tregs by ADCC using anti-human CCR4 mAb (KM2760) （Poster notice，General）
6.	2013/09/30	Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb. （Poster notice，General）
7.	2013/09/30	Prolonged overall survival in XAGE-1b(GAGED2a) antibody positive NSCLC patients. （Poster notice，General）
8.	2013/04/06	Depletion of Tregs from PBMCs by treatment with defucosylated anti-CCR4 mAb （Poster notice，General）
9.	2013/04/06	Immune response to XAGE-1b (GAGED2a) in NSCLC patients and its clinical relevance （Poster notice，General）
10.	2012/10/01	Treg depletion from PBMCs by treatment with defucosylated anti-human CCR4 mAb （Poster notice，General）
11.	2012/04/12	Thin-section CT imaging of patients with pulmonary mycobacterium infections: Comparison between Mycobacterium kansasii and Mycobacterium tuberculosis （Speech，General）
12.	2011/04/22	非結核性抗酸菌症の診断に対する2つのinterferon-gamma release assay(IGRA)の臨床評価（Poster notice，General）
Display 5 items
Display all(12)

■ Belonging society

2010/01～

American Association for Cancer Research